Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03401333 · ClinicalTrials.gov registry record · NA

Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use

A NA study of Alcohol Drinking and Marijuana, sponsored by Yale University.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03401333 is a NA study of Alcohol Drinking and Marijuana that has completed, run by Yale University. The registered enrollment target is 10 participants, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03401333, a NA study of Alcohol Drinking and Marijuana, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This study tests the feasibility of an intervention to prevent risky alcohol or marijuana use that adds a 4-week course of tailored text messaging to a brief motivational intervention for 13-18-year-old adolescents.

Interventions

  • BEHAVIORAL Text Messaging and Brief Negotiation Interview

Study Locations (1)

Connecticut

  • Yale New Haven Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-11-14
Est. Completion 2018-06-06
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT03401333

The ClinicalTrials.gov registry entry for NCT03401333 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (98% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Text Messaging and Brief Negotiation Interview is the first listed.

NCT03401333 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT03401333 about?

NCT03401333 is a clinical study titled "Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use". This study tests the feasibility of an intervention to prevent risky alcohol or marijuana use that adds a 4-week course of tailored text messaging to a brief motivational intervention for 13-18-year-old adolescents.

What is the current status of trial NCT03401333?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-11-14. Estimated completion is 2018-06-06.

What conditions does trial NCT03401333 study?

This clinical trial studies the following conditions: Alcohol Drinking, Marijuana.

What interventions are being tested in trial NCT03401333?

The interventions under investigation include: Text Messaging and Brief Negotiation Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT03401333?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03401333 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.